Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C28H33N7O2 |
| Molecular Weight | 502.6258 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[2H]C([2H])([2H])N1C=C(C2=C1C=CC=C2)C3=CC=NC(NC4=CC(NC(=O)C=C)=C(C=C4OC)N(C)CCN(C)C)=N3
InChI
InChIKey=DUYJMQONPNNFPI-VPYROQPTSA-N
InChI=1S/C28H33N7O2/c1-7-27(36)30-22-16-23(26(37-6)17-25(22)34(4)15-14-33(2)3)32-28-29-13-12-21(31-28)20-18-35(5)24-11-9-8-10-19(20)24/h7-13,16-18H,1,14-15H2,2-6H3,(H,30,36)(H,29,31,32)/i5D3
| Molecular Formula | C28H33N7O2 |
| Molecular Weight | 502.6258 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 19:46:16 GMT 2025
by
admin
on
Wed Apr 02 19:46:16 GMT 2025
|
| Record UNII |
9EKD2E8BM5
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
300000054547
Created by
admin on Wed Apr 02 19:46:16 GMT 2025 , Edited by admin on Wed Apr 02 19:46:16 GMT 2025
|
PRIMARY | |||
|
1638281-46-5
Created by
admin on Wed Apr 02 19:46:16 GMT 2025 , Edited by admin on Wed Apr 02 19:46:16 GMT 2025
|
PRIMARY | |||
|
12936
Created by
admin on Wed Apr 02 19:46:16 GMT 2025 , Edited by admin on Wed Apr 02 19:46:16 GMT 2025
|
PRIMARY | |||
|
87056175
Created by
admin on Wed Apr 02 19:46:16 GMT 2025 , Edited by admin on Wed Apr 02 19:46:16 GMT 2025
|
PRIMARY | |||
|
C206877
Created by
admin on Wed Apr 02 19:46:16 GMT 2025 , Edited by admin on Wed Apr 02 19:46:16 GMT 2025
|
PRIMARY | |||
|
9EKD2E8BM5
Created by
admin on Wed Apr 02 19:46:16 GMT 2025 , Edited by admin on Wed Apr 02 19:46:16 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
IRREVERSIBLE INHIBITOR
|
||
|
NON-LABELED -> LABELED |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
METABOLITE ACTIVE -> PARENT |
The AUC and Cmax of osimertinib increased sharply after deuteration. Systemic exposure of AZ5104 was remarkably reduced.
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|